Fahad Khaliq/X
Jan 7, 2026, 08:50
Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
Fahad Khaliq, Doctor of Medicine at Allied Hospital, Faisalabad, reposted from Muhammad Moor on X:
”Faster, potent, better, reversible, better mortality results
But here’s the plot twist!
If a patient is already on anticoagulation/high risk bleed, Clopidogrel is preferred
Rule of thumb:
• STEMI pt undergoing PCI: Ticagrelor
• STEMI pt undergoing Thrombolysis: Clopidogrel”
Quoting Muhammad Moor‘s post:
”Why is Ticagrelor sometimes preferred over other antiplatelets in acute coronary syndrome (ACS)?”
Stay updated with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity